[music]
We create an architecture which is representative of the
architecture and the organization of cells inside the body.
Borrowing tools from nature, Sri Kidambi builds a structured environment
where cancer cells can grow.
Then he steps back and lets biology kick in.
This is cancer in a dish.
So this will give us the ability to really have a
personalized tumor in a dish for each patient.
Cells organize themselves into patterns on these
platforms; the structures allow doctors to recreate
hundreds of versions of a tumor and then try out different treatments without involving the patient.
So here's a platform which will potentially will have a way of screening
which will be a promising treatment regimen.
End goal is make patient's treatment regimens available right now
more flexible and also more efficient to the patients.
Pharmaceutical companies will benefit because the technology
speeds up the development of new treatments.
Kidambi's research also sheds light on the disease process
and how cells interact.
Create a platform which can be explored, utilized for people
for drug screening or understanding various diseases
and make people's lives much better in the long run.
[It stained all the acidic...]
NUtech Ventures helps Kidambi explore potential partners
and navigate the complex world of patents.
For Kidambi, the ultimate payoff is innovation that helps others.
I don't want my science to die in the lab.
I want to take it beyond.
I want it to make an imprint, make a difference in people's life.
[music]